Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yah we’re still waiting on the official announcement from OMNI as well.
I'd say this one isn't languishing - it's up about 500% from pre-custodianship application levels already. It's off the radar for now and a low floater, which means there are fewer traders involved and chatting about it. These take more patience. There are advantages and disadvantages to low floaters and to high liquidity shells - they all play out differently....
Horst, I know you've been involved with these custodian ships for a while and seem to know what is going on. I guess I'm curious as to why something like CHME Which has a small market cap at the current share value, Lower shares and float in general then most, And old enough to most likely be passed all liability issues.... Why do these languish when some of those that sharp deals with are much more risky and yet shoot up to 100 400 600% and ones like this just Languish?
Thanks Horst. Picked up a starter here. Very low SS on this one.
Nice! Thanks for the update.
Granted as expected...
If anyone wants to look it up, it's case A-21-831008-C at Clark County Courts: https://www.clarkcountycourts.us/
I just ordered the most recent Clark County Courts doc from April 21 out of curiosity. It included a notice of non-opposition, and stated that Omni had left a copy of the summons and complaint with CHME's registered agent listed with NVSOS back in mid-March, and had also tried to serve/notify all other relevant parties, but heard nothing back in all this time. With that information, the judge had moved the custodian appointment hearing up to May 5th from June. Generally these old defunct Nevada tickers go to the custodian applicants without any trouble anyway, and Omni has one of the tried and true custodianship lawyers in Jay Shafer, so imo this custodianship being granted today is extremely highly probable. Could be wrong of course - no guarantees ever in the custodianship process - but all indicators would point towards an easy appointment imo.
Just my opinion....
H
Right, the market cap is attractive. I assume it's not popular because Omni just isn't as well known as others. Hopefully things go well and we can get more attention after having a positive update to share/spread around. $CHME
I was able to get some in the 4s as a lotto play. Kind of curious why this hasn't got the same hype as the other custodian ships. It's got far less then a billion shares and value cap is under 2 million and it hasnt existed for so long most debts and shareholder issue should be non existent. You would think this would be the perfect reverse merger takeover play.
This float will be one for the record books.. CHME
May 5, 2021.
$CHME China Medicine Corporation updates: Application for Appointment of Custodian A-21-831008-C has been updated to May 5th. We're working hard!
Added here. Custodianship play... CHME
Tough day for CHME today - down 27%.
CHME document from China Lawyer back in 2016 showing CEO Yang Senshan bought 3.3M shares from two other co-founders at a price of Chinese Yuan 2.6, which is around $0.4 USD
Link to the lawyer document
http://pdfcdn2.ipo3.com/quasi_notices/upload/201606/30/42305_1467274429_216024.pdf
Chinese copy see Page 59
Google translate to English
(3) Liu Minhua, Liu Junhua exit CMC
According to the "United States Legal Opinion", October 25, 2015, Liu Minhua, Liu Junhua and Hongsheng (incense
Hong Kong Investment Co., Ltd. (hereinafter referred to as "Hongsheng Company") signed the "Share Purchase and Transfer Agreement", Liu Min
Hua, Liu Junhua holds all of its shares in CMC (2,662,000 shares and 653,000 shares respectively)
RMB 2.6 yuan price transfer to the Hongsheng company.
According to Hongsheng's "Business Registration Certificate", "Annual Report" and other information, Hongsheng company has issued
The shares are 10,000 ordinary shares and are held by HONG SHENG INVESTMENT INC. according to
HONG SHENG INVESTMENT INC. 'S company registration information, board of directors and other information, HONG
SHENG INVESTMENT INC. Is the shareholder of Yang Sen Shan.
According to Yang Senshan, Liu Minhua, Liu Junhua provided "online bank back to the single", three issued by the statement and
Commitment, Yangsen Hill has been paid to Liu Minhua, Liu Junhua transferee CMC shares of the price.
After the completion of the equity transfer, Liu Minhua, Liu Junhua no longer hold CMC shares.
Kang Zuen Group will hold 100% stake in Kang Zuen foreign transfer and Liu Minhua, Liu Junhua will hold
CMC shares after the transfer, Kang Zaien red chip structure all cleared.
CHME 0.15x0.16
CHME OEP website added it to "Realized Investments"!!
http://www.oneequity.com/RealizedInvestments
This is going to be HUGE!
OEP's last SC 13g before CHME went dark
Shared Voting Power
18,472,560*
One Equity Partners is the private merchant banking arm of JPMorgan Chase,[1] focused on leveraged buyout and growth capital investments in middle-market companies. Formed at Bank One in 2001, the group has offices in New York City, Chicago, Sao Paulo, Vienna, Hong Kong and Frankfurt. It manages approximately $10 billion of investments and capital commitments by JPMorgan Chase.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8826929
.16 now Im a believer CHME
I think this could still trade after a cash divy. So would hate to put a .40 GTC and have a special dividend hit Finra.lol Especially if its a few bucks. It would be probably during market hours opposed to pre market or AH and stock price would go up heavily.imo
If sub is going public and the parent goes public do you think there will be a special divy THEN a full cash-out divy from the parent? In that case it would still trade a little while from first divy then get a full on cash out some time later which would delist stock afterward on last one.
not sure just saying. Ive seen multi divies before over a year on a lot of dormant stocks.
CHME HEADING TO $0.4 for 1st stop
CHME 0.08 X 0.09 monster subsidiary IPO in China
So whats going on with CHME, had this a long time ago and just noticed some activity here. On watch.
we only need to see the $$
Chinees is not my favourate language, I can see the pictures but don't understand it at all.
CHME 0.02 50K bidder. looking good
go and check their Chinese webpage. check the news date 07-30-2015
http://www.konzern.com.cn/
I am happy to hear that, they really exist , but why there are not shares bought or sold????? The market does not exist for them or only to go lower? Do they have earning, do they sell products, I mean Chme.
CHME DD INFO; 0.0105 X 0.013 NEXT CH*G
CHME DD - very quiet buying happening. One to keep an eye on:
O/S only 27 mil.
http://www.cmc621.com/about/index.php?id=1
OEP is the major holder for CHME, which is the branch of JPMorgan Chase
CHME company found on OEP website.
www.oneequity.com/AllCompanies
CHME shows One Equity Partners (OEP) owns 42.7% of the company.
Major Direct Holders (Forms 3 & 4)
OEP CHME HOLDINGS, LLC 8,333,334 Dec 30, 2010
www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8826929
OEP CHME Holdings, LLC operates as a subsidiary of OEP Parent LLC.
http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=256554989
One Equity Partners (OEP) makes private equity investments behind compelling business ideas and strong management teams. Since inception in 2001, OEP has managed approximately $14 billion in total investments and committed capital for JPMorgan Chase & Co., and OEP has delivered strong returns throughout this thirteen year period.
http://www.oneequity.com/About_1
CHME company is alive! company news link shows
Development of Overseas Market—Technical Service in Pakistan9 Dec 2014
In order to further expand overseas markets, our company sent technical staff to our exclusive agent Ghazi Brothers in Pakistan for technical services. As the largest distributor in Pakistan, Ghazi Brothers started the sale of our product Feed additive-Aflatoxin B1-detoxinfizyme in 2012. Due to the increasing customer number and growing market demand, our company accepted Ghazi Brothers’ invitation and went to Pakistan with the purpose of helping them exploit the new market.
http://www.uskonzern.com/content.php?lid=7
Who We Are
We are a leading pharmaceutical and nutraceutical group in China, specialized in dietary supplement, medicine, and biotech projects. Invested by China Medicine Cooperation, USA (NASQ Symbol: CHME.OB)., Konzern Group Limited was established in 2010 based on Guangzhou Konzern Medicine Co., Ltd., which has more than ten years of history in medicine and nutraceutical selling in China.
Now we have a R&D Centre with cutting-edge technology, which makes us the carrier of 863 Program (National High-tech R&D Program of China) and Guangdong Important Science and Technology Project.
CHME looks good. In yesterday.
CHME 0.03 huge buy
CHME 0.012 BIDS STACKING
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against China Medicine Corporation
| 12:31 PM |
LOS ANGELES--(BUSINESS WIRE)--Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Central District of California on behalf of a class consisting of all persons or entities who purchased the common stock of China Medicine Corporation (“China Medicine” or the “Company”) (OTC:CHME) between November 30, 2006 and March 23, 2011, inclusive (the “Class Period”). A copy of the Complaint is available from the court or f
Related News: Similar Content http://feeds.businesswire.com/click.phdo?i=e8ca46bc41c8aa02df6701229d729884#rssowlmlink
CHME Security Details
Share StructureMarket Value1 $17,784,046 a/o Aug 08, 2011
Shares Outstanding 23,712,061 a/o Nov 10, 2010
Float Not Available
Authorized Shares Unlimited a/o
Par Value 0.0001
http://www.ccgirasia.com/
Investment manager at CLSA Capital Partners (HK) Ltd? Look like a private equity fund manager to me. Well, IMHO, OEP probably gave some "suggestions" about the new CFO position as well as the new board. That's nice. This management certainly need some fresh air.
OEP: Don't forget to find out what's really going on in rADTZ.
Sounds good to me!
Long time holder. I'm usually not so patient!
China Medicine Appoints New CFO, Nominates Three New Directors
China Medicine Appoints New CFO, Nominates Three New Directors
just thought that was worth sharing. must be the only person following these days that's a great indicator.
ratobranco, did you get the reply email? personally I don't think whether the contract is enforceable or not is important. JPM/OEP is a major owner/partner and it will be foolish to trick JPM into an unenforceable contract. So I believe it is enforceable. The question is how much penalty/compensation we have to give to them if management fail to achieve the financial target. With the major delay in radtz it has become the more and more likely outcome.
Another question to speculate is : Does JPM/OEP know the delay when they negociate with management since the events are so close together? Do they have a full handle of the situation? Frankly I will be upset if I just enter a partnership and boom my partner give me a surprise by announcing a major delay of an very important product.
CHME - No Dilution?
Actually, the fourth interpretation starts to yield a positive number at ~ $11M EBITDA, which is still less than 2009. With lifetech income and possible rATDZ, I don't think $11M is anything to worry about.
CHME - Deal Yields Incoherent Result? No Dilution?
I really want to urge people to take a closer look at the share subscription agreeemnt between CHME and OEP. I know that it's painful for the brain, but there is a lot of money to be made here if the makegood aspect of the share subscription agreeement turns out to be uneforceable due to generating an incoherent result. With rATDZ, uplisting, and the Wall Street credibility that comes from being majority owned by JP Morgan, CHME is an easy one year double from here--long term probably a ten bagger. The only obstacle is the share subscription agreement, specifically, the possibility that current shareholders could suffer further dilution. And what I'm saying is that it might not be an enforceable agreeement.
The problem has to do with the interpretation of the following phrases:
(1) "Total Number of Equity Securities of the Company Issued and Oustanding on a Fully Diluted Basis"
(2) "Total Number of Common Shares on a Fully Diluted Basis"
The term "Company" is defined to mean China Medicine Corporation.
The phrase "Fully Diluted Basis" is defined as follows:
“Fully Diluted Basis” means (i) the number of Common Shares which would be outstanding if all securities convertible into or exchangeable for Common Shares held by all Person were converted or exchanged in full and (ii) as applied to a particular Person, the number of Common Shares which would be held by such Person if all securities convertible into, exchangeable for or exercisable for Common Shares held by such Person were converted or exchanged or exercised in full.
The question is, is there any difference between (1) and (2)? If so, what is the difference? How do we interpret these phrases?
I've written an excel spreadsheet that calculates the number of shares to be given to OEP upon various interpretations of phrases (1) and (2). The first interpretation only gives a coherent result if EBITDA falls below ~ $8M, which is 66% of 2009 EBITDA, hardly a concern at this point. I get incoherent results for the second and third interpretations. The fourth interpretation yields coherent results, but it doesn't make sense linguistically, and it involves a use of phrase (2) that is in conflict with the way the same phrase is used in other parts of the document.
http://webspace.utexas.edu/bdp366/CHME_OEP_Analysis.xls
I could easily be missing something obvious, so I need some backup here. I already have a position, but if this agreement is not going to mean anything, then I want a bigger position. At the current prices, much bigger.
I have an email in to Crocker Coulson, he's supposed to get back to me. I'll let people know what comes of this.
anyone figure out dilution?
i'm interested but staying away till i can get a feel for dilution.
CHME
Looking for $2.90
Nice bounce back
I am playing the CHME bounce like i played LPIH and FUQI.
I sold both of them a little earlier than i should have.
I guess the 10K was better than most who
jumped ship thought it would be.
The stock sold off in a worst case scenario.
Well see.I am hoping to see if she can approach 4 again ?
Without radtz contribution and 6 -8 mil from LifeTech in 2010 I wonder if they can meet 25mil EBITDA target for 2010. It is harder to squeeze more profit out of their distribution business.
When they talked with OEP about the stock subs. agreement they probably still saw they could get some good high margin profit from radtz in 2010 also I believe their forcast for LifeTech is higher(10-12 mil). It is April now so I think they know q1 and a bit about q2 business. I think probably it is wise to not expect much when the 1st q report comes out.
Lifetech for sure had a postive effect. They also stated that their intention is to discontinue low margin distrubtion business and replace it with higher margin self-owed products. They quoted 6% of of revenue (think) was self owned in 2009 and they were looking to increase it.
Even if the revenue does not increase then the bottom line should show some growth.
rich
Followers
|
34
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
607
|
Created
|
11/30/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |